Close Menu

Editor's Pick

The researchers developed a protocol for dengue and chikungunya virus detection, which they plan to continue to test for outbreak monitoring and diagnostics.

DeCode's new offering adds to an ongoing controversy over whether people in the island country have a right to know if they are at increased risk for disease.

HHS may already be administering DNA testing to migrant families, but the agency has provided little information about how testing is being implemented.

Researchers at Columbia University and CHOP believe they can shorten time to diagnosis and improve yield by extracting phenotypic data from EHRs for genomic labs.

The company plans to use the new funding to grow its suite of genomics applications to more than 50 in 2018.

The company outlined its plans to launch a kidney transplant rejection test that is based on cell-free DNA in 2019 and described its progress in breast cancer research.

The court's ruling that Quest was acting as a licensed healthcare provider could affect the statute of limitations in the suit.

The companies have launched a center that offers consulting and management specifically for genomically targeted or precision medicine trials.

The new assay simultaneously detects four viral targets in donated blood plasma in a single sample and can add value to the biologics development space.

On the heels of the WINTHER study, the consortium has planned a new trial called MERCURY, and will launch a blood and tissue repository.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.